2023-07-01 2024-06-30 false Capium Accounts Production 1.1 09091368 2023-07-01 2024-06-30 09091368 bus:FullAccounts 2023-07-01 2024-06-30 09091368 bus:Micro-entities 2023-07-01 2024-06-30 09091368 bus:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 09091368 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 09091368 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 09091368 2023-07-01 2024-06-30 09091368 2024-06-30 09091368 bus:RegisteredOffice 2023-07-01 2024-06-30 09091368 core:WithinOneYear 2024-06-30 09091368 core:AfterOneYear 2024-06-30 09091368 1 2023-07-01 2024-06-30 09091368 bus:Director1 2023-07-01 2024-06-30 09091368 bus:Director1 2024-06-30 09091368 bus:Director1 2022-07-01 2023-06-30 09091368 bus:Director2 2023-07-01 2024-06-30 09091368 bus:Director2 2024-06-30 09091368 bus:Director2 2022-07-01 2023-06-30 09091368 bus:Director3 2023-07-01 2024-06-30 09091368 bus:Director3 2024-06-30 09091368 bus:Director3 2022-07-01 2023-06-30 09091368 bus:Director4 2023-07-01 2024-06-30 09091368 bus:Director4 2024-06-30 09091368 bus:Director4 2022-07-01 2023-06-30 09091368 2022-07-01 09091368 bus:LeadAgentIfApplicable 2023-07-01 2024-06-30 09091368 2022-07-01 2023-06-30 09091368 2023-06-30 09091368 core:WithinOneYear 2023-06-30 09091368 core:AfterOneYear 2023-06-30 09091368 bus:EntityAccountantsOrAuditors 2022-07-01 2023-06-30 09091368 core:CostValuation core:Non-currentFinancialInstruments 2024-06-30 09091368 core:CostValuation core:Non-currentFinancialInstruments 2023-06-30 09091368 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-06-30 09091368 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-06-30 09091368 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-06-30 09091368 core:Non-currentFinancialInstruments 2024-06-30 09091368 core:Non-currentFinancialInstruments 2023-06-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 09091368
England and Wales

 

 

 

MEDISENSE MEDICO-LEGAL LTD


Unaudited Financial Statements
 


Period of accounts

Start date: 01 July 2023

End date: 30 June 2024
Directors Rubina Rahman
Samah Kanwal Alizai
Naved Kamal Alizai
Nabil Alizai
Registered Number 09091368
Registered Office Penny Hill
Hollywell Green, Halifax
HX4 9PZ
Accountants ASK ACCOUNTANTS UK LTD
178
Merton High Street
London
SW19 1AY
1
  2024   2023
    £ £   £ £
Current assets 272,141      109,350   
Creditors: amount falling due within one year (61,488)     (31,691)  
Net current assets   210,653      77,659 
Total assets less current liabilities   210,653      77,659 
Net assets   210,653      77,659 
 

         
Capital and reserves   210,653      77,659 
 
NOTES TO THE ACCOUNTS

General Information
Medisense Medico-Legal Ltd is a private company, limited by shares, registered in England and Wales, registration number 09091368, registration address Penny Hill, Hollywell Green, Halifax, HX4 9PZ.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of services supplied by the company, net of Value Added Tax and trade discounts.
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
2.

Average number of employees

Average number of employees during the year was 0 (2023 : 0).

3.

Advances and Credits



Advance
Included within Debtors are the following loan to the director:

Current year (2024)
Brought Forward
£
Amount
£
Interest
£
Repaid
£
Written Off
£
Waived
£
Carry Forward
£
Advance
0000000
Previous year (2023)
Brought Forward
£
Amount
£
Interest
£
Repaid
£
Written Off
£
Waived
£
Carry Forward
£
Advance39,600 39,600 
039600039600000

For the year ended 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 06 February 2025 and were signed on its behalf by:


--------------------------------
Naved Kamal Alizai
Director
2